— Know what they know.
Not Investment Advice
Also trades as: 0I7E.L (LSE) · $vol 0M

DVA NYSE

DaVita Inc.
1W: +3.6% 1M: +2.1% 3M: -24.6% YTD: +58.7% 1Y: +40.7% 3Y: +134.4% 5Y: +61.0%
$181.69
-2.34 (-1.27%)
 
Weekly Expected Move ±5.3%
$164 $174 $184 $193 $203
NYSE · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 55 · $11.6B mcap · 62M float · 1.26% daily turnover · Short 74% of daily vol
Credit Risk of going bust: higher than 68% of companies Debt: 48.2% of company value Bonds: $637.0M held by 409 funds, 150 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $12.23 (down 93%), DaVita Inc. would be worth roughly what it owes.
Total debt $10.78B against a stock market value of $11.59B.
Distance to default 3.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $5.45B (short-term plus half of long-term), stock volatility 45.2%; Altman Z'' 1.24. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

7 relationships
3
As Filer
counterparties named
4
As Counterparty
mentioned by others
2
Rel. Types
2022-04-08
Earliest Filing
2025-11-25
Latest Filing
partner: 2 investor: 1

Counterparties (Filed by DVA)

3 relationships

Companies named in DVA's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
DNB Carnegie, Inc. — partner Senior managing agent. 2025-11-25 View
Santander Bank, N.A. — partner Senior managing agent. 2025-11-25 View
Berkshire Hathaway Inc. BRK-A investor DaVita Inc. entered into a share repurchase agreement with Berkshire Hathaway Inc. to maintain its beneficial ownership 2024-05-01 View

Mentioned As Counterparty

4 mentions

Other companies that named DVA in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
RMTI ROCKWELL MEDICAL, INC. supplier Amended and restated products purchase agreement for dialysis concentrates 2023-09-21 View
NUWE Nuwellis, Inc. partner Entered into a Supply and Collaboration Agreement for a pilot program of the Aquadex ultrafiltration therapy system. 2023-06-21 View
RMTI ROCKWELL MEDICAL, INC. supplier Amended supply agreement for dialysis concentrates and securities purchase agreement for preferred stock 2022-04-08 View
RMTI ROCKWELL MEDICAL, INC. investor Investor in Series X Convertible Preferred Stock issuance 2022-04-08 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-04 Earnings Release; Exhibits View
2026-06-08 Material Agreement; Financial Obligation; Shareholder Vote; Exhibits Agreement View
2026-05-05 Earnings Release; Exhibits View
2026-02-02 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-25 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2025-10-29 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-20 Other Events View
2025-08-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-17 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2025-06-09 Submission of Matters to a Vote of Security Holders View
2025-05-23 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2025-05-20 Other Events; Financial Statements and Exhibits View
2025-05-20 Other Events; Financial Statements and Exhibits View
2025-05-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-14 Other Events View
2025-02-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-29 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-09-13 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2024-09-05 Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits View
2024-08-14 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms